Dr. Gregg Sylvester, MD - Chief Health Officer, CSL Seqirus - Lessening The Severity Of Influenza

Dr. Gregg Sylvester, MD is Chief Health Officer and Vice President, Medical Affairs, at CSL Seqirus ( https://www.cslseqirus.us/our-company/leadership/gregg-sylvester ), one of the world’s largest influenza vaccine companies.

Dr. Sylvester has led CSL Seqirus Medical Affairs since 2016, overseeing the global team that scientifically differentiates company’s vaccines by generating Real World Evidence and presenting CSL Seqirus research to national vaccine recommending organizations.

Dr. Sylvester has extensive experience in the pharmaceutical industry, government and patient care.

Prior to joining CSL Seqirus, Dr. Sylvester led Medical Affairs teams at Pfizer and Merck involved in the worldwide launches of vaccines including Gardasil (Human Papillomavirus Vaccine), Prevnar 13 (Pneumococcal Conjugate Vaccine) and Trumenba (Meningococcal Group B Vaccine).

Dr. Sylvester obtained specialty boards in Pediatrics and General Preventive Medicine. Augmenting his clinical expertise, he served in the CDC Epidemic Intelligence Service and as a Public Policy Fellow in the U.S. Congress.

During his distinguished career in state government, Dr. Sylvester was appointed to the Cabinet Secretary for Health and Social Services in Delaware, leading the state’s largest agency.

Dr. Sylvester has a MD from Albany Medical College and an MPH from the Johns Hopkins Bloomberg School of Public Health.

#GreggSylvester #CSLSeqirus #Influenza #Vaccine #FluShot #ProgressPotentialAndPossibilities #IraPastor #Podcast #Podcaster #ViralPodcast #STEM #Innovation #Technology #Science #Research